Global recommendations on child medicine

Transparent information on the evidence supporting global recommendations on paediatric medicines should be easily accessible in order to help policy makers decides on what drugs to include in their national drug lists, according to international experts from Ghana and the UK writing in this week's PLOS Medicine.

The authors, led by David Sinclair from the Liverpool School of Tropical Medicine, report the experiences of the Ghana National Drugs Programme as it reviewed the international evidence base for five priority paediatric medicines* in order to decide whether or not to include them in Ghana's essential medicines list.

According to the authors, applying the global recommendations to Ghana was not straightforward for any of the five medicines, despite high quality evidence of important clinical benefits, because of the unproven effect of the drugs in African settings and the scant information on and the supply chain.

After the authors did their own review of the evidence on the effectiveness of these medicines to the situation and context of Ghana, they decided to include only four out of the five medicines in the national essential medicines list.

They say: "This project demonstrates why global recommendations should be presented alongside transparent descriptions of the evidence base, allowing policy makers to identify where, when, and how the interventions have been evaluated, and any factors limiting wider applicability."

The authors argue: "In addition, for interventions where feasibility and affordability are likely to vary from setting to setting, the could further assist national decision-makers by providing implementation guidance on the assessment of implications, training and , and country level cost analyses."

They conclude: "As many policy questions are relevant across sub-Saharan Africa, and policy makers are likely to encounter recurrent problems, we encourage regional collaboration on health technology assessment, and sharing of information and resources."

More information: Sinclair D, Gyansa-Lutterodt M, Asare B, Koduah A, Andrews E, et al. (2013) Integrating Global and National Knowledge to Select Medicines for Children: The Ghana National Drugs Programme. PLoS Med 10(5):e1001449. doi:10.1371/journal.pmed.1001449

*oral zinc sulphate for acute diarrhoea, injectable artesunate for severe malaria, topical chlorhexidine for preventing neonatal cord sepsis, dispersible oral amoxicillin for community acquired pneumonia, and oral and injectable caffeine citrate for neonatal apnoea.

add to favorites email to friend print save as pdf

Related Stories

IOM urges international action to eradicate fake drugs

Feb 14, 2013

(HealthDay)—Falsified and substandard medications pose public health problems around the world, and international action should be taken to combat the phenomenon, according to a report published Feb. 13 ...

FDA device will screen for fake medicines overseas

Apr 24, 2013

U.S. health officials are making a high-tech screening device available to African authorities to help spot counterfeit malaria pills in hopes that the technology may eventually be used to combat the fake drug trade worldwide.

Recommended for you

Seniors successfully withdraw from meds

20 hours ago

Elderly people have proved receptive to being de-prescribed medications, as part of a trial aimed at assessing the feasibility of withdrawal of medications among older people.

Flu vaccine for expectant moms a top priority

Sep 18, 2014

Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.

Experts want restrictions on testosterone drug use (Update)

Sep 17, 2014

Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans ...

User comments